Vanguard Personalized Indexing Management’s GSK GSK Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.15M | Buy |
82,069
+397
| +0.5% | +$15.2K | 0.04% | 425 |
|
|
2025
Q1 | $3.16M | Buy |
81,672
+16,748
| +26% | +$649K | 0.05% | 352 |
|
|
2024
Q4 | $2.2M | Sell |
64,924
-3,882
| -6% | -$131K | 0.03% | 453 |
|
|
2024
Q3 | $2.81M | Buy |
68,806
+11,282
| +20% | +$461K | 0.05% | 359 |
|
|
2024
Q2 | $2.21M | Buy |
57,524
+7,011
| +14% | +$270K | 0.04% | 377 |
|
|
2024
Q1 | $2.17M | Buy |
50,513
+11,074
| +28% | +$475K | 0.05% | 372 |
|
|
2023
Q4 | $1.46M | Buy |
39,439
+2,346
| +6% | +$86.9K | 0.04% | 459 |
|
|
2023
Q3 | $1.34M | Buy |
37,093
+2,053
| +6% | +$74.4K | 0.04% | 432 |
|
|
2023
Q2 | $1.25M | Buy |
35,040
+5,060
| +17% | +$180K | 0.04% | 467 |
|
|
2023
Q1 | $1.07M | Buy |
29,980
+8,270
| +38% | +$294K | 0.04% | 498 |
|
|
2022
Q4 | $763K | Sell |
21,710
-476
| -2% | -$16.7K | 0.03% | 623 |
|
|
2022
Q3 | $653K | Sell |
22,186
-4,204
| -16% | -$124K | 0.03% | 672 |
|
|
2022
Q2 | $1.44M | Buy |
26,390
+6,138
| +30% | +$334K | 0.07% | 298 |
|
|
2022
Q1 | $1.1M | Buy |
20,252
+5,493
| +37% | +$299K | 0.05% | 401 |
|
|
2021
Q4 | $814K | Buy |
14,759
+4,648
| +46% | +$256K | 0.05% | 496 |
|
|
2021
Q3 | $483K | Buy |
10,111
+1,119
| +12% | +$53.5K | 0.04% | 530 |
|
|
2021
Q2 | $448K | Buy |
8,992
+968
| +12% | +$48.2K | 0.05% | 535 |
|
|
2021
Q1 | $358K | Buy |
8,024
+619
| +8% | +$27.6K | 0.05% | 438 |
|
|
2020
Q4 | $341K | Sell |
7,405
-2,023
| -21% | -$93.2K | 0.07% | 319 |
|
|
2020
Q3 | $444K | Buy |
9,428
+843
| +10% | +$39.7K | 0.12% | 196 |
|
|
2020
Q2 | $438K | Buy |
+8,585
| New | +$438K | 0.2% | 123 |
|